Manejo de la hiperglucemia en el paciente con enfermedad oncológica avanzada (EOA)

Glycaemic disorders frequently occur in patients with advanced cancer, even in those who have never been diagnosed as having diabetes, due to treatments and/or clinical conditions that affect glycaemic homeostasis. Hyperglycaemia management in patients with advanced cancer is complex, due to the lack of consensus on frequency of controls, intensity of treatment and glycaemic targets. The absence of prospective studies further hampers evidence-based recommendations. However, the topicality of this important clinical issue merits a comprehensive revision of the available literature, aimed at improving communication between health professionals and, ultimately, ameliorating patient care.This review will focus on the most recent data on the management of blood glucose in patients with advanced cancer, and will try to highlight the most relevant clinical aspects which should guide treatment choices.